SEP 13, 2017 9:55 AM PDT

Protecting B Cells from Cancer-Inducing DNA Damage

WRITTEN BY: Kara Marker

DNA damage in cells can lead to cancer, so why do B cells of the immune system intentionally damage their own DNA? A new study shows that doing so improves the diversity of antibodies, which better allows the immune system to fight infections. But with the risks involved in this process, B cells need to be ready to combat the negative side effects.

This is a microscopy image showing collections of mRNA molecules, called RNA granules (green), inside B cells that are altering their genes to produce antibodies. DNA is shown in blue. Credit: Dr Manuel Díaz-Muñoz

From the Babraham Institute, scientists are studying how B cells direct programmed DNA damage during development, damage which is even more severe than when it occurs naturally. Additionally, the repair processes that are put in place to take care of normal damage don’t work fast enough, so B cells have to intervene to ensure the damage doesn’t weaken the immune system or lead to cancer.

B cells alter their genes to build better antibodies to fight infection. The process of damaging and repairing DNA can help B cells create specific antibodies needed to treat certain infections.

"B cells walk a fine line, some DNA damage is needed for them to make effective antibodies to fight infections, but too much and they become harmful,” explained first author Manuel Diaz-Munoz, PhD. “It's a tough situation to manage biochemically.”

The solution, Diaz-Munoz and the other researchers found, is that B cells start the repair process early in preparation for intentional DNA damage. And with the help of a protein called Tia1, they can safely do so.

Researchers found that Tia1 helps B cells manage the activity of DNA repair genes, which are always active. Before, it was thought that these genes turn on and off according to B cells’ needs. However, it is Tia1 that controls these genes, which ultimately produce the proteins required for the the DNA damage response.

“This is an attractive and little explored mechanism that we are now starting to understand,” explained senior scientist Martin Turner, PhD. “Controlling protein production in this way is important in other healthy and diseased cells and it will be interesting to see if a similar system exists in other places."

The present study was published in the journal Nature Communications.

Source: Babraham Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 14, 2019
Genetics & Genomics
SEP 14, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
DEC 04, 2019
Immunology
DEC 04, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
New Injection that Treats Peanut Allergy
Peanut allergies affect between 1 and 3% of the US population. Associated with a heightened risk of severe anaphylactic reactions, oral immunotherapy is th...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
JAN 28, 2020
Immunology
JAN 28, 2020
Infectious Parasite Manipulates the Immune System to Survive
Toxoplasma gondii suppresses the immune system of the hosts it infects – human or otherwise – just enough to survive, thrive, and move on to mo...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently infected. Having made top news storie...
Loading Comments...